The global hematology market is divided into hematology products& hematology services. The hematology products segment holds the largest share of the hematology market in 2014. It is also expected to grow at the highest CAGR in the next five years, owing to the increasing development of new hematology reagents. In addition, based on the end-users, the global hematology market has been segmented into commercial organizations, stand-alone hospitals, research institutes, and clinical testing labs. The clinical testing labs holds the largest share of the hematology market in 2014 and is poised to grow at a CAGR of 4.5% in the forecast period.
The global hematology analyzers and reagents market is expected to reach $3.13 billion by 2019, at a CAGR of 5.2% from 2014 to 2019.
On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and RoW (Latin America, Middle East, and Africa). In 2014, the global hematology analyzers and reagents market was dominated by North America.
Technological advancements, rising incidence/prevalence of patients suffering from blood disorders, increasing funding to research institutes, and presence of large number of well established hematology firms in the region are driving the growth of the hematology analyzers and reagents market in the North American countries.
Get PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=153222146
However, the Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019 due to factors such as developing healthcare infrastructure, large patient population, increasing funding/investment towards the development of hematology products, growing focus of both international and domestic players on the Asia-Pacific countries.
Key factors such as developments in the high throughput hematology analyzers and advancements in high sensitivity point-of-care (POC) hematology testing are propelling the growth of the global hematology instruments and reagents market. In addition, integration of basic flow-cytometry techniques in modern hematology analyzers and increasing adoption of automated hematology instruments by diagnostic laboratories is further fueling the growth of this market.
Abbott Laboratories (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Boule Diagnostics AB (Sweden),HORIBA, Ltd. (Japan), Mindray Medical International Limited (China), Nihon Kohden Corporation (Japan), Roche Diagnostics (Switzerland), Siemens AG (Germany), and Sysmex Corporation (Japan)are the key players operating in the global hematology analyzers and reagents market.
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets